-+ 0.00%
-+ 0.00%
-+ 0.00%

SILEXION THERAPEUTICS CORP - TO INITIATE PHASE 2/3 TRIAL OF SIL204 IN ISRAEL AND GERMANY

Reuters·06/23/2026 12:40:00

Please log in to view news